SCHEMBL13610465

SCHEMBL13610465

c1cnc2sc(SSSCc3ccc4nonc4c3)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 2/20 0.52
ALDH1A1 P00352 8/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALOX15 P16050 2/20 0.39
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.35
ALOX12 P18054 1/20 0.35
POLB P06746 1/20 0.34
TOP2A P11388 2/20 0.33
KMT2A Q03164 1/20 0.33
FBP1 P09467 2/20 0.32
KCNJ1 P48048 1/20 0.32
KCNH2 Q12809 1/20 0.32
NPC1 O15118 3/20 0.32
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
DRD2 P14416 1/20 0.31
HPGD P15428 1/20 0.31
ADRA2B P18089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610444 0.81 PDK1 (0.51) PDK1ALDH1A1HSD17B10ALOX15SMN1; SMN2
SCHEMBL13610361 0.80 PDK1 (0.58) PDK1ALDH1A1SMN1; SMN2POLBKMT2A
SCHEMBL13610460 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610326 0.77 ALDH1A1 (0.56) PDK1ALDH1A1MAPK1SMN1; SMN2POLB
SCHEMBL13610398 0.77 PDK1 (0.51) PDK1SMN1; SMN2TOP2ARAB9AKDM4E
SCHEMBL13610485 0.75 PDK1 (0.61) PDK1ALDH1A1TSHRHSD17B10ALOX15
SCHEMBL13610382 0.75 PDK1 (0.51) PDK1ALDH1A1POLBNPC1RAB9A
SCHEMBL13610503 0.72 PDK1 (0.57) PDK1ALDH1A1HSD17B10ALOX15SMN1; SMN2
SCHEMBL13610522 0.72 PDK1 (0.57) PDK1ALDH1A1TSHRHSD17B10ALOX15
SCHEMBL13610454 0.71 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS PDK1 2965/4885ALDH1A1 285/4885TSHR 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.